STOCK TITAN
  1. Home
  2. ICUSF

ICUSF Stock Price, News & Analysis

ICUSF OTC

Company Description

ICUSF (OTC: ICUSF) is a publicly traded medical specialties company in the Health Technology sector.

This page provides a comprehensive overview of ICUSF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
—

IceCure Medical Shares to Begin Trading on Nasdaq Capital Market on August 26, 2021

—

/C O R R E C T I O N -- IceCure Medical/

—

IceCure Announces One-for-(8) Reverse Stock Split in Preparation for Nasdaq Listing

stock split
—

IceCure Medical Announces Exclusive $6.6M Distribution Agreement to Sell ProSense™ Cryoablation System in Brazil

—

Positive Interim Results from IceCure Medical's ICE3 Clinical Trial for Breast Cancer Treatment by Freezing with the ProSense® Cryoablation System Presented at the 2021 ASBrS Meeting

clinical trial
—

IceCure Medical Announces Upcoming Presentation at the American Society of Breast Surgeons Annual Meeting

conferences

ICUSF has 7 recent news articles. Key topics include stock split, clinical trial, conferences, fda approval. View all ICUSF news →

SEC Filings

View All

No SEC filings available for ICUSF.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ICUSF Company Profile & Sector Positioning

ICUSF (ICUSF) operates in the Medical Specialties industry within the broader Health Technology sector and is listed on the OTC.